Navigation Links
Evotec to Present at the Cowen and Company 28th Annual Health Care Conference in Boston
Date:3/14/2008

HAMBURG, Germany and OXFORD, England, March 14 /PRNewswire-FirstCall/ -- Evotec AG (Frankfurt Stock Exchange: EVT) today announced that Jorn Aldag, President & CEO and Dr John Kemp, Chief Research & Development Officer will present at the Cowen and Company 28th Annual Health Care Conference in Boston.

Date: Tuesday, March 18, 2008

Time: 11.00 am EDT (04.00 pm CET/03.00 pm GMT)

Venue: The Boston Marriott Copley Place Hotel, Boston, US

A live webcast of the presentation will be accessible through the Evotec website at http://www.evotec.com - Investors. A replay will be available at http://www.evotec.com - Investors - Webcasts.

Contact:

Evotec AG,

Anne Hennecke,

SVP, Investor Relations & Corporate Communications,

Phone: +49(0)40-56081-286,

Fax: +49(0)40-56081-333,

E-Mail: anne.hennecke@evotec.com.


'/>"/>
SOURCE Evotec AG
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Evotec to Present Details of the Positive Phase II Study in Insomnia With EVT 201 at the Worldsleep07 Congress in Cairns/Australia
2. Evotec Reports Details of the Positive Proof-of-Concept Phase II Study in Insomnia With EVT 201
3. Evotec to Present at the UBS 2007 Global Life Sciences Conference in New York
4. Evotec AG: R&D Update on 16 October 2007 Live on the Internet
5. Evotec Reports Third Quarter 2007 Results
6. Evotec Appoints Mario Polywka and Klaus Maleck to the Management Board
7. Evotec Provides Update on Planned NASDAQ Listing in the Context of its Announced Acquisition of Renovis
8. Evotec to Present at the BIO CEO & Investor Conference 2008 in New York
9. Evotec Extends Ongoing Collaboration With CHDI Worth up to US$ 37 Million
10. Evotec Starts Phase II in Smoking Cessation with EVT 302
11. Evotec Expands Collaboration With InterMune
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/15/2017)... ... June 15, 2017 , ... Cybrexa Therapeutics, ... B round of financing in the amount of $6 million. An investment vehicle ... in the round. , The Series B funding will enable Cybrexa to complete ...
(Date:6/14/2017)... ... June 14, 2017 , ... Slone Partners ... initiative steered by the executive search firm, “Building Value in Precision Medicine: Can ... Directors of Foundation Medicine, led an open discussion with expert panelists Troy Cox, ...
(Date:6/14/2017)... ... ... The newest company to join the Science Center’s Port business incubator is creating ... a spin out of the University of Michigan, will occupy lab space at 3624 ... Its founders are among the first wave of researchers adopting into translational science the ...
(Date:6/13/2017)... ... June 13, 2017 , ... Three newly formed companies have ... program. PolyCeramX, Recensa Therapeutics and Regennera, all P1V participants, will apply the funds ... Ventures is a startup accelerator that helps launch and grow companies that have ...
Breaking Biology Technology:
(Date:4/11/2017)... No two people are believed to ... York University Tandon School of Engineering and Michigan ... partial similarities between prints are common enough that ... and other electronic devices can be more vulnerable ... in the fact that fingerprint-based authentication systems feature ...
(Date:4/6/2017)... , April 6, 2017 ... RFID, ANPR, Document Readers, by End-Use (Transportation & Logistics, ... Facility, Oil, Gas & Fossil Generation Facility, Nuclear Power), ... Educational, Other) Are you looking for a ... sector? ...
(Date:4/5/2017)... -- Today HYPR Corp. , leading innovator in ... the HYPR platform is officially FIDO® Certified . ... that empowers biometric authentication across Fortune 500 enterprises and ... 15 million users across the financial services industry, however ... suites and physical access represent a growing portion of ...
Breaking Biology News(10 mins):